Spero Therapeutics (SPRO) Operating Margin (2017 - 2025)
Spero Therapeutics (SPRO) operating margin from Jun 30, 2017 to Dec 31, 2025. The current Spero Therapeutics (SPRO) operating margin is 249.88%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Spero Therapeutics (SPRO)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 50.12% | -100.25% |
| 2024 | -19827.03% | -958.43% |
| 2023 | 2309.68% | -236.83% |
| 2022 | -1688.00% | -41.09% |
| 2021 | -2865.47% | -90.58% |
| 2020 | -30426.92% | +2181.30% |
| 2019 | -1333.76% | +23.69% |
| 2018 | -1078.34% | -48.84% |
| 2017 | -2107.58% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | -9770.59% | N/A |
Comparison Spero Therapeutics (SPRO) operating margin with competitors
Spero Therapeutics (SPRO) operating margin is 249.88%.